CLSI M35

Abbreviated Identification of Bacteria and Yeast, 2nd Edition

This document provides the minimum identification criteria that can be used to rapidly identify organisms commonly isolated from clinical specimens.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of April 2016. The document’s next scheduled review is generally five years after the reaffirmation date.

This document is available in electronic format only.

More Details

Member price:

List Price:

Details

Chairholder: Mary Jane Ferraro, PhD, MPH

Date of Publication: November 24, 2008

Order Code PDF: CLSI M35A2E
ISBN Number: 1-56238-681-6

Order Code Print: print not available

Edition: Second

Pages: 64

CLSI M35 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

CLSI M35 Abstract

Clinical and Laboratory Standards Institute document M35-A2—Abbreviated Identification of Bacteria and Yeast; Approved Guideline—Second Edition includes the minimum identification criteria that can be used to rapidly identify a limited number of organisms commonly isolated from patient specimens. Although these tests do not rule out an occasional misidentification, those errors may not have important consequences with regard to patient outcome. Those situations in which rapid test results may have limitations are described. Unless those exceptions provide clinically useful information, confirmatory identification need not be done.